Literature DB >> 1608116

Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.

D H Thom1, J T Grayston, D S Siscovick, S P Wang, N S Weiss, J R Daling.   

Abstract

OBJECTIVE: To evaluate the association between prior infection with Chlamydia pneumoniae, as measured by IgG antibody, and coronary artery disease.
DESIGN: A population-based, case-control study.
SETTING: Group Health Cooperative of Puget Sound, a Seattle-based health maintenance organization. PARTICIPANTS: Men 55 years of age and younger and women 65 years of age and younger. Cases (n = 171) were members of Group Health Cooperative undergoing diagnostic coronary angiography who had at least one coronary artery lesion occupying 50% or more of the luminal diameter. The population controls (n = 120) were Group Health Cooperative members without known coronary heart disease. MAIN OUTCOME MEASURE: The adjusted odds ratio (OR) for coronary artery disease associated with prior C pneumoniae infection as measured by the presence of IgG antibody.
RESULTS: After adjusting for age, gender, and calendar quarter of blood drawing, the OR for coronary artery disease associated with the presence of antibody was 2.6 (95% confidence interval, 1.4 to 4.8). The association was limited to cigarette smokers, in whom the OR was 3.5 (95% confidence interval, 1.7 to 7.0). Among never-smokers, the OR was 0.8 (95% confidence interval, 0.3 to 1.9). When cases and controls were restricted to those assayed concurrently, the adjusted OR (smokers and nonsmokers combined) was 4.2 (95% confidence interval, 1.8 to 10.0). Adjustment for serum cholesterol, hypertension, alcohol use, diabetes, and socioeconomic status did not change these results. Only a week association was found when cases were compared with 63 subjects whose angiographic results were normal (OR, 1.2; 95% confidence interval, 0.6 to 2.2).
CONCLUSIONS: These results generally support the previously reported association between C pneumoniae infection and coronary heart disease. However, caution should be used in interpreting the basis for this association.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1608116

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  61 in total

1.  Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; L Ballam; J Morris; B K Butland; P M Sweetnam; P C Elwood
Journal:  BMJ       Date:  1999-04-17

Review 2.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  Immunological basis of Chlamydia induced reactive arthritis.

Authors:  J S Gaston
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

4.  T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.

Authors:  A J Curry; I Portig; J C Goodall; P J Kirkpatrick; J S Gaston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis.

Authors:  M Maurin; F Eb; J Etienne; D Raoult
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 6.  Systemic diseases caused by oral infection.

Authors:  X Li; K M Kolltveit; L Tronstad; I Olsen
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

7.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

8.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

9.  Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells.

Authors:  Anthony A Azenabor; Godwin Job; Olanrewaju O Adedokun
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

10.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.

Authors:  P Patel; M A Mendall; D Carrington; D P Strachan; E Leatham; N Molineaux; J Levy; C Blakeston; C A Seymour; A J Camm
Journal:  BMJ       Date:  1995-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.